VECCHIO, DOMIZIA
 Distribuzione geografica
Continente #
EU - Europa 826
NA - Nord America 683
AS - Asia 203
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 1.719
Nazione #
US - Stati Uniti d'America 674
IE - Irlanda 325
SE - Svezia 134
IT - Italia 132
DE - Germania 116
UA - Ucraina 63
HK - Hong Kong 58
SG - Singapore 50
CN - Cina 48
CZ - Repubblica Ceca 14
FI - Finlandia 14
IN - India 14
IR - Iran 14
CA - Canada 9
FR - Francia 9
TR - Turchia 6
VN - Vietnam 6
BE - Belgio 5
EU - Europa 3
GB - Regno Unito 3
GR - Grecia 3
KR - Corea 3
MA - Marocco 3
PK - Pakistan 3
PL - Polonia 3
NL - Olanda 2
RU - Federazione Russa 2
BR - Brasile 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 1.719
Città #
Dublin 323
Jacksonville 126
Chandler 70
Hong Kong 58
Wilmington 45
Dearborn 40
Lawrence 37
Princeton 37
Singapore 30
Boardman 26
Bremen 26
Piemonte 22
Beijing 19
Ann Arbor 16
San Mateo 15
Brno 14
Monmouth Junction 14
Grafing 13
Ashburn 12
Milan 9
Novara 8
Georgetown 7
Cologne 6
Dong Ket 6
Leawood 6
Strasbourg 6
Torino 6
Toronto 6
Brussels 5
Andover 4
Cagliari 4
Galliate 4
Guangzhou 4
Helsinki 4
Kunming 4
Nanchang 4
Ardabil 3
Bari 3
Carate Brianza 3
Cilavegna 3
Des Moines 3
Düsseldorf 3
Fairfield 3
Gangnam-gu 3
Hefei 3
Houston 3
Jinan 3
Kocaeli 3
Mohammedia 3
Mülheim 3
Nanjing 3
Norwalk 3
Tehran 3
Tortona 3
Turin 3
Zakroczym 3
Zanjan 3
Albuzzano 2
Amsterdam 2
Casale Monferrato 2
Concordia sulla Secchia 2
Dallas 2
Galway 2
Izmir 2
Munich 2
New York 2
Noicattaro 2
Nuremberg 2
Priocca 2
Redwood City 2
Sacramento 2
San Francisco 2
Vercelli 2
Winnipeg 2
Woodbridge 2
Yekaterinburg 2
Bangalore 1
Belo Horizonte 1
Berlin 1
Brindisi 1
Bulandshahr 1
Cambridge 1
Cassano Magnago 1
Chengdu 1
Genoa 1
Gunzenhausen 1
Hebei 1
Horia 1
Huzhou 1
Istanbul 1
Ivrea 1
Lissone 1
Macerata 1
Mcallen 1
Mumbai 1
Nichelino 1
Nocera Inferiore 1
Nürnberg 1
Ottawa 1
Philadelphia 1
Totale 1.161
Nome #
Kappa free light chains could predict early disease course in multiple sclerosis 80
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis 78
Kappa free light chains as a biomarker in multiple sclerosis 76
A novel synonymous mutation in the MPZ gene causing an aberrant splicing pattern and Charcot-Marie-Tooth disease type 1b 62
Auditory seizures in autoimmune epilepsy: a case with anti-thyroid antibodies 61
K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up 54
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility 52
The Yin-Yang of osteopontin in nervous system diseases: Damage versus repair 52
Combined use of Kappa Free Light Chain Index and Isoelectrofocusing of Cerebro-Spinal Fluid in Diagnosing Multiple Sclerosis: Performances and Costs 51
A patient with autoimmune limb-girdle myasthenia, and a brief review of this treatable condition 49
MOG-antibody demyelinating diseases: a case of post-partum severe rhombencephalitis and transverse myelitis 48
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial 48
Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple Sclerosis 48
The burden of multiple sclerosis variants in continental Italians and Sardinians 46
Effects of Venous Angioplasty on Cerebral Lesions in Multiple Sclerosis: Expanded Analysis of the Brave Dreams Double-Blind, Sham-Controlled Randomized Trial 46
Burden of rare coding variants in an Italian cohort of familial multiple sclerosis 46
Thalamic hemiataxia 45
Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibility 45
Holmes tremor caused by a natalizumab-related progressive multifocal leukoencephalopathy: a case report and brief review of the literature 45
Location of first attack predicts the site of subsequent relapses in multiple sclerosis 45
An investigation of the role of common and rare variants in a large italian multiplex family of multiple sclerosis patients 45
Intrathecal kappa free light chains as markers for multiple sclerosis 44
Severe rebound of spinal cord multiple sclerosis activity after fingolimod withdrawal 43
The impact of lifetime coffee and tea loads on Multiple Sclerosis severity 40
Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis 40
Cerebral nervous system vasculitis in a Covid-19 patient with pneumonia 39
Factors predicting severity and duration of MS relapses: a prospective study 37
Post-lumbar puncture headache: an adverse effect in multiple sclerosis work-up 36
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy 34
Susac Syndrome: an uncommon cause of impaired vision 34
Cannabinoids in multiple sclerosis: A neurophysiological analysis 33
Paraneoplastic neuromyelitis optica spectrum disorders: a case series 32
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 31
Role of the C-terminal fragment of osteopontin in multiple sclerosis 30
Efficacy of Cannabinoids on Spasticity and Chronic Pain in a Patient with Co-occurrence of Multiple Sclerosis and Neurofibromatosis Type 1 29
Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis 28
Early Successful Eye Movement Desensitization and Reprocessing (EMDR) Therapy for Verbal Memory Impairment in an Adjustment Disorder: A Case Report in a Newly-Diagnosed Multiple Sclerosis Patient 23
Serum vitamin d as a marker of impaired information processing speed and early disability in multiple sclerosis patients 21
Early Predictors of Disability and Cognition in Multiple Sclerosis Patients: A Long-Term Retrospective Analysis 20
The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis 20
Exploring serum and CSF Calcitonin Gene Related Peptide levels: A promising biomarker in multiple sclerosis? 18
Prognostic Role of Visual Evoked Potentials in Non-Neuritic Eyes at Multiple Sclerosis Diagnosis 12
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 7
Parkinson's disease and chronic inflammatory demyelinating polyneuropathy: Broadening the clinical spectrum of VCP mutations 6
CGRP beyond migraine: exploring its serum and CSF levels in multiple sclerosis. 6
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY) 5
The Role of Diet in Multiple Sclerosis Onset: A Prospective Study Using UK Biobank 3
Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patients 2
Totale 1.795
Categoria #
all - tutte 10.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020203 0 2 20 0 27 28 45 10 29 17 24 1
2020/2021186 19 2 27 0 22 15 26 5 27 3 33 7
2021/2022284 26 4 30 15 13 3 31 13 21 23 40 65
2022/2023688 43 32 50 10 55 59 33 24 326 4 29 23
2023/2024339 26 18 26 12 36 13 62 15 14 5 31 81
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 1.795